JCO Oncology Advances
Wolters Kluwer Health - Lippincott Williams Wilkins · United States
Aims & Scope
Subject areas: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens. Topics: oncology, global health, cancer research, clinical medicine, cancer, public health
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Research Topics (OpenAlex)
Frequently asked questions about JCO Oncology Advances
Is JCO Oncology Advances a predatory journal?
PubScope has no integrity flags on record for JCO Oncology Advances: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 52/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of JCO Oncology Advances?
JCO Oncology Advances is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor.
Is JCO Oncology Advances indexed in Scopus and Web of Science?
JCO Oncology Advances is indexed in DOAJ.
What is the aims and scope of JCO Oncology Advances?
Subject areas: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens. Topics: oncology, global health, cancer research, clinical medicine, cancer, public health
How much does it cost to publish in JCO Oncology Advances?
JCO Oncology Advances charges an article processing charge (APC) of about $3,800 for open-access publication.
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref